Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001104659-25-100535
Filing Date
2025-10-20
Accepted
2025-10-17 21:54:11
Documents
3
Period of Report
2025-10-17

Document Format Files

Seq Description Document Type Size
1 FORM 6-K tm2528875d1_6k.htm 6-K 22898
2 EXHIBIT 1.1 tm2528875d1_ex1-1.htm EX-1.1 293532
3 EXHIBIT 5.1 tm2528875d1_ex5-1.htm EX-5.1 7772
  Complete submission text file 0001104659-25-100535.txt   325191
Mailing Address 804, 322 - 11 AVENUE SW CALGARY A0 T2R 0C5
Business Address 804, 322 - 11 AVENUE SW CALGARY A0 T2R 0C5 4036707380
ONCOLYTICS BIOTECH INC (Filer) CIK: 0001129928 (see all company filings)

EIN.: 000000000 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-38512 | Film No.: 251402219
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)